Navigation Links
Acorda's Ampyra Sustains High Levels of Interest Seven Months After Launch With Favorable Future Share Projections
Date:12/13/2010

EXTON, Pa., Dec. 13, 2010 /PRNewswire/ -- BioTrends Research Group, Inc. finds that on most metrics, perceptions of Acorda's Ampyra, the first FDA-approved product for the management of a multiple sclerosis (MS) symptom, have remained consistent or improved since earlier waves, including product awareness, interest, satisfaction, the managed care process and Acorda's patient support program. Compared to early in the launch, patient requests play a less impactful role in Ampyra uptake. With increased familiarity after seven months on the market, neurologists are gaining a clear picture of the discontinuation rates, responder rates and insurance dynamics associated with Ampyra.

The recently released third and final wave of the LaunchTrends®: Ampyra report series finds that about half of the surveyed neurologists had been detailed on Ampyra within the past month.  Those considered high prescribers of the brand recall dialogue related to reimbursement. While market share of Ampyra was not significantly different compared to the prior wave, the respondents report starting significantly more dalfampridine-naive patients on Ampyra compared to earlier waves. More than three-quarters of the surveyed neurologists currently prescribe Ampyra and projected market share increases for the brand are expected to come from both an expanded user base as well as increased use among current prescribers.

LaunchTrends®: Ampyra is a three wave syndicated report series designed to track the uptake of Acorda's Ampyra at one month, four months and seven months following its commercial availability. In the current wave of research, which measures Ampyra's market impact at seven month post-launch, BioTrends surveyed 76 neurologists and conducted qualitative interviews with a subset of 20 of the respondents in November 2010. BioTrends will continue to track the uptake of Ampyra in TreatmentTrends®: Multiple Sclerosis,
'/>"/>

SOURCE BioTrends Research Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis
2. Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004
3. Tocotrienols Shown to be Effective in Lowering Fat Levels in Blood
4. U.S. FDA Approves New Oral Contraceptive That Also Raises Folate Levels
5. People at Intermediate Risk of Heart Disease With Elevated hsCRP Benefit From Statin Therapy Even if Cholesterol Levels are Normal
6. FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels
7. Single Dose of Proprietary Adult Stem Cells Regenerates Damaged Pancreas and Reduces Blood Glucose Levels in Diabetes
8. New Published Study Shows Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Reliably Determines Carbon Monoxide Levels in the Blood
9. FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
10. Studies Show AFRESA(R) Controls Post-Meal Sugar Levels With Less Weight Gain and Hypoglycemia Risk for Diabetes Patients
11. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oct. 22, 2014   Surefire Medical , Inc., ... designed to maximize targeted delivery of embolization agents in ... that oncologist John R. Daniels , MD of ... and surgical oncologist Steven C. Katz , MD ... Company,s Scientific Advisory Board (SAB).    "The ...
(Date:10/22/2014)... 22, 2014 Sanomedics International Holdings, Inc. (OTCQB: ... Global Research & Data Services, demand for thermometers is ... through 2018, as demand for more accurate digital thermometers ... the world,s largest market for thermometers, and one of ... Sanomedics International Holdings, Inc. Sanomedics International Holdings ...
(Date:10/22/2014)... and AUSTIN, Texas ... and PureMHC LLC today announced they have entered ... novel antibody-based immunotherapies designed to target cancers. ... phosphorylated peptides displayed on the surfaces of tumor ... tumor targets (PTTs), derived from proteins that play ...
Breaking Medicine Technology:Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2
(Date:10/25/2014)... News) -- Arriving home safe and sound is one of ... be sure that costumes and goody bags have reflective strips ... emergency medicine doctor at Meadowlands Hospital Medical Center in Secaucus, ... costumes should be flame-resistant, Davis said. He offers these ... test it on a small area of skin first to ...
(Date:10/25/2014)... Dallas, TX (PRWEB) October 25, 2014 ... and Chinese Molecular Diagnostics Industry, 2009-2019 is ... Global and Chinese Molecular Diagnostics industry. The ... Molecular Diagnostics including its classification, application and ... and China’s top manufacturers of Molecular Diagnostics ...
(Date:10/25/2014)... Limbkeepers® announced today that they will be ... Begley Jr, airing 1st QTR 2015 via Discovery Channel. ... Innovations will focus on Limbkeepers® non compression knit sleeves, ... on arms, hands, and legs from abrasion, skin tears ... which help reduce injuries, allow for continued daily activities, ...
(Date:10/25/2014)... A large influx of international aid is needed, and ... thousands of deaths from the widening Ebola crisis, a ... a specially designed mathematical model, the researchers looked at ... densely populated county of hard-hit Liberia -- Montserrado County, ... researchers said that if international aid isn,t delivered to ...
(Date:10/22/2014)... October 22, 2014 On Saturday, October 25, ... fourth annual family health and fitness fair ¡Vive tu vida! ... activity and good nutrition for better health and wellness for ... is free and open to the public, will be held ... from 9:00 am to 1:00 pm. , “¡Vive tu ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid Delayed 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4
... N.C., March 25 There is no guarantee ... after its initial launch. A,necessary first step for ... that ensures needed resources -- both financial and,staffing ... a study by benchmarking,leader Best Practices, LLC., ...
... Stanford University School of Medicine,s Todd Ferris, Associate ... of Information Privacy and Security; ... Engineer, WHAT: "Improving Network Security and Management", WHEN: ... EDUCAUSE Western Regional Conference 2008 ...
... March 25 Laerdal Medical,Corporation announces a ... MedAssets Supply Chain Systems has awarded Laerdal,a ... Products." The,contract is effective January 1 through ... ), Bruce Cadwell, Laerdal,s National ...
... Cancer with State-of-the-Art Technology, EAST RUTHERFORD, N.J., ... of the nation,s top 10 public relations firms, ... roster. Developed in New,Zealand, MoleSafe is a state-of-the-art ... moles and other suspicious lesions to,help detect early ...
... 25 Almost Family, Inc.,(Nasdaq: AFAM ) today ... home health agency owned by Apex Home Healthcare,Services, L.L.C. ... Company Comments on Combination, "We are very pleased ... of Apex to our Company, and we are excited ...
... pathogens - including ,superbug, MRSA-responsible ... March 25 The U.S. Environmental Protection,Agency (EPA) ... public health claims. These public health claims acknowledge ... harmful, potentially deadly,bacteria. Copper is the first solid ...
Cached Medicine News:Health News:Successful Drug Re-Launch Hinges on Organizational Backing 2Health News:Stanford University School of Medicine to Address 'Improving Network Security and Management' at EDUCAUSE Western Regional Conference 2008 Using Lancope's StealthWatch System for Network Behavior Analysis 2Health News:Laerdal Medical Announces Strategic Relationship 2Health News:MWW Group Retained by MoleSafe 2Health News:Almost Family Announces Acquisition of Apex Home Health 2Health News:Almost Family Announces Acquisition of Apex Home Health 3Health News:Almost Family Announces Acquisition of Apex Home Health 4Health News:U.S. EPA Approves Registration of Antimicrobial Copper Alloys 2
... preservative free lubricating and rewetting ... eyes while you're wearing soft ... free formula is ideal for ... to preservatives and for frequent ...
Saline Solution to rinse and store soft contact lenses and for heat disinfection....
Sensitive Eyes Plus Saline Solution to rinse soft contact lenses The unique, gentle, pH-balanced formula contains potassium, an ingredient found in tears....
... instruments have been designed to provide ... tool for situations requiring precise hemostasis. ... 25 gauge intraocular, bipolar, diathermy instruments. ... target tissues for fine-tip hemostasis or ...
Medicine Products: